Boardroom Alpha
Boardroom Alpha
DORM · Current Report (Form 8-K) · Filed January 20, 2026

Dorman Products Inc — Current Report (Form 8-K)

Form
8-K
Filed
January 20, 2026
Period
Jan 19, 2026
Ticker
DORM
Accession
0000868780-26-000004
Boardroom Alpha · Filing insights

Dorman appoints Charles Rayfield as CFO designate; David Hession shifts to advisory role with CEO through 2027.

About Dorman Products Inc
Market cap
$3.8B
1Y TSR
−4.7%
3Y TSR
+13.6%
Board grade
B-
Sector
Consumer Cyclical
CEO
Kevin M Olsen
Last annual meeting: May 15, 2026 · View full Dorman Products Inc profile →
dorm-20260119

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 19, 2026
gpe304xr1jov000001.jpg
DORMAN PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania000-1891423-2078856
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
3400 East Walnut Street, Colmar, Pennsylvania 18915
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:  (215) 997-1800
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 Par ValueDORMThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o



Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Appointment of Charles W. Rayfield as Chief Financial Officer
On January 19, 2026 (the “Start Date”), Dorman Products, Inc. (the “Company”) announced the appointment of Charles W. Rayfield as Senior Vice President, Chief Financial Officer Designate, and Treasurer of the Company effective January 19, 2026.
Mr. Rayfield, age 46, most recently served as Chief Financial Officer of Lutron Electronics Corporation, a leading designer and manufacturer of lighting control and shading systems, lighting fixtures, and accessories for residential and commercial applications, since June 2023. Prior to that, Mr. Rayfield provided independent financial advisory services from November 2022 to June 2023, and he served as Chief Financial Officer of Knoll Inc., then a publicly traded company and a leading global manufacturer of commercial and residential furniture, accessories, lighting and coverings, from August 2017 to July 2021.
Pursuant to an offer letter dated December 10, 2025 (the “Offer Letter”), Mr. Rayfield will serve as Chief Financial Officer Designate from the Start Date until he assumes the roles of Senior Vice President, Chief Financial Officer, Treasurer, and principal financial officer of the Company, effective as of the first business day following the date on which the Company files its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Transition Date”).
Mr. Rayfield’s annualized base salary will be $525,000, and he will be eligible for an annual performance bonus target of 75% of his base salary under the Company’s Amended and Restated Cash Bonus Plan. Mr. Rayfield will receive a sign-on cash bonus of $350,000 (less applicable withholdings and taxes) payable in March 2026. The sign-on cash bonus is subject to repayment on a prorated basis if Mr. Rayfield’s employment is terminated by the Company for cause or if he terminates his employment voluntarily within twenty-four (24) months from his Start Date. Mr. Rayfield will be eligible to participate in the Company’s 2018 Stock Option and Stock Incentive Plan and any successor plan, and his target equity award opportunity will be $500,000; provided, however, that with respect to the Company’s annual equity grant cycle in March 2026, Mr. Rayfield will be eligible for a target equity award opportunity of $600,000.
Mr. Rayfield will enter into the Company’s customary employee non-disclosure, invention assignment and restrictive covenant agreement that includes, among other things, non-competition and non-solicitation covenants for the twelve (12) month period following his employment with the Company.
There is no arrangement or understanding between Mr. Rayfield and any other person pursuant to which he was selected as an officer, nor does Mr. Rayfield have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Mr. Rayfield has no family relationships with any of the Company's directors or executive officers.
A copy of the Offer Letter is attached hereto as Exhibit 10.1 and incorporated herein by reference. The foregoing description of the Offer Letter is qualified in its entirety by reference to the full text of the Offer Letter.
Transition of David M. Hession to Advisor to the President and Chief Executive Officer
As previously disclosed in the Company’s Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on June 5, 2025, Mr. David M. Hession notified the Company of his intention to retire as Chief Financial Officer of the Company. Pursuant to a transition agreement dated January 19, 2026 (the “Transition Agreement”), Mr. Hession will continue to serve as the Company's Chief Financial Officer and principal financial officer (collectively, the "Current Roles") until the Transition Date, after which he will continue his employment as Advisor to the Company’s President and Chief Executive Officer (the “Advisory Role”). It is contemplated that Mr. Hession will serve in the Advisory Role through March 5, 2027, after which he is expected to retire from the Company.
Under the Transition Agreement, effective as of the Transition Date, Mr. Hession’s annualized base salary will be adjusted to $50,000 and he will no longer be eligible to participate in the Company’s annual cash bonus program. However, he will remain eligible to receive an annual cash bonus award under the Company’s



Amended and Restated Cash Bonus Plan for fiscal 2025 and for fiscal 2026, but any award for fiscal 2026 will be prorated through the Transition Date based on his target award (adjusted based on actual financial results for the fiscal year) and the number of days worked in his Current Roles. During the period in which he serves in the Advisory Role, any outstanding equity awards held by Mr. Hession through March 5, 2027 will remain outstanding and eligible to vest in accordance with their terms.
A copy of the Transition Agreement is attached hereto as Exhibit 10.2 and incorporated herein by reference. The foregoing description of the Transition Agreement is qualified in its entirety by reference to the full text of the Transition Agreement.
Responsibilities of Jeffrey L. Darby, Senior Vice President, Sales & Marketing
Effective as of January 19, 2026, Mr. Jeffrey L. Darby, the Company’s Senior Vice President, Sales & Marketing, will assume the role of Senior Vice President, Enterprise Sales, and will begin to assist the Company with strategic sales and marketing opportunities across the enterprise. Previously, Mr. Darby engaged in sales and marketing activities primarily for the Company’s Light Duty segment only.
Item 7.01 Regulation FD Disclosure.
On January 19, 2026, the Company issued a press release announcing, among other things, the appointment of Mr. Rayfield and the transition arrangement with Mr. Hession.
Item 9.01    Financial Statements and Exhibits.  
(d)    Exhibits
Exhibit NumberDescription
10.1
10.2
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document).



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DORMAN PRODUCTS, INC.
Date:
January 20, 2026
By:/s/ Joseph P. Braun
Name:Joseph P. Braun
Title:
Senior Vice President, General Counsel & Corporate Secretary

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Dorman Products Inc (DORM)

Reference

Frequently asked questions

When did Dorman Products Inc file this 8-K?
Dorman Products Inc (DORM) filed this Current Report (Form 8-K) with the SEC on January 20, 2026. The accession number assigned by EDGAR is 0000868780-26-000004.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Dorman appoints Charles Rayfield as CFO designate; David Hession shifts to advisory role with CEO through 2027. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Dorman Products Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Dorman Products Inc has filed under CIK 868780, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer